iStock-1311515392_edited.png

Revolutionizing
Payer Research

Market Access Transformation (MAT) specializes in developing agile technology platforms that enable healthcare manufacturers to gather insights and assess the commercial viability of their products.

 

See first hand how we provide the most robust and timely insights to our biopharmaceutical and healthcare clients around the world through both Rapid Payer Response (RPR) and Envision.

RPR Intro
Play Video
Screen Shot 2021-10-06 at 4.29.35 PM.png

Rapid Payer Response (RPR) is an agile, on-demand platform that allows you to conduct the most robust, insightful, research via direct payer engagement. 

Updated Envision Graphic_edited_edited_e
Screen Shot 2021-10-06 at 4.29.19 PM.png

Envision™ is the only sydicated research platform that provides forward thinking evaluations of the market access viability for a product after it has received positive EMA or FDA guidance.

GLOBAL CLIENTS

nestle_ao_alto_BW.png
eisai_BW.png
astellas_B&W.png
Advanz_BW_1.png
Amryt_BW.png
alnylam_pharmaceuticals_logoBW.png
DePuy_BW.png
daiichi-sankyo-seeklogo_BW.png
Biogen-01_BW.png
Braeburn_logo-mainlogo_BW.png
bayer_BW.png
Air_Liquide_B&W.png
adaptive-biotechnologies-logo-vector_BW.png
gw-pharmaceuticals-logo_BW.png
Genentech-Logo_BW.png
debiopharm-logo-vector_BW.png
Chinook_logo_BW.png

NEWS AND UPDATES view all
The latest MAT case studies, thought leadership, events, and news